Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages

Nak Yun Sung, Mi So Yang, Du Sub Song, Jae Kyung Kim, Jong Heum Park, Beom Seok Song, Sang Hyun Park, Ju Woon Lee, Hyun Jin Park, Jae Hun Kim, Eui Baek Byun, Eui Hong Byun

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Polyphenolic compounds have been found to possess a wide range of physiological activities that may contribute to their beneficial effects against inflammation-related diseases; however, the molecular mechanisms underlying this anti-inflammatory activity are not completely characterized, and many features remain to be elucidated. In this study, we investigated the molecular basis for the down-regulation of toll-like receptor 4 (TLR4) signal transduction by procyanidin dimer B2 (Pro B2) in macrophages. Pro B2 markedly elevated the expression of the interleukin (IL)-1 receptor-associated kinase (IRAK)-M protein, a negative regulator of TLR signaling. Lipopolysaccharide (LPS)-induced expression of cell surface molecules (CD80, CD86, and MHC class I/II) and production of pro-inflammatory cytokines (tumor necrosis factor-α, IL-1β, IL-6, and IL-12p70) were inhibited by Pro B2, and this action was prevented by IRAK-M silencing. In addition, Pro B2-treated macrophages inhibited LPS-induced activation of mitogen-activated protein kinases such as extracellular signal-regulated kinase 1/2, p38, and c-Jun N-terminal kinase and the translocation of nuclear factor κB and p65 through IRAK-M. We also found that Pro B2-treated macrophages inactivated naïve T cells by inhibiting LPS-induced interferon-γ and IL-2 secretion through IRAK-M. These novel findings provide new insights into the understanding of negative regulatory mechanisms of the TLR4 signaling pathway and the immune-pharmacological role of Pro B2 in the immune response against the development and progression of many chronic diseases.

Original languageEnglish
Pages (from-to)122-128
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume438
Issue number1
DOIs
Publication statusPublished - 2013 Aug 16

Fingerprint

Interleukin-1 Receptor-Associated Kinases
Toll-Like Receptor 4
Macrophages
Dimers
Lipopolysaccharides
Polyphenolic compounds
Signal transduction
Mitogen-Activated Protein Kinase 3
T-cells
JNK Mitogen-Activated Protein Kinases
Interleukins
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinases
Interleukin-1
Interferons
Interleukin-2
procyanidin
procyanidin B2
Interleukin-6
Signal Transduction

Keywords

  • Cytokine
  • Mitogen-activated protein kinases
  • Nuclear factor κB
  • Procyanidin B2
  • Toll-like receptor

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages. / Sung, Nak Yun; Yang, Mi So; Song, Du Sub; Kim, Jae Kyung; Park, Jong Heum; Song, Beom Seok; Park, Sang Hyun; Lee, Ju Woon; Park, Hyun Jin; Kim, Jae Hun; Byun, Eui Baek; Byun, Eui Hong.

In: Biochemical and Biophysical Research Communications, Vol. 438, No. 1, 16.08.2013, p. 122-128.

Research output: Contribution to journalArticle

Sung, NY, Yang, MS, Song, DS, Kim, JK, Park, JH, Song, BS, Park, SH, Lee, JW, Park, HJ, Kim, JH, Byun, EB & Byun, EH 2013, 'Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages', Biochemical and Biophysical Research Communications, vol. 438, no. 1, pp. 122-128. https://doi.org/10.1016/j.bbrc.2013.07.038
Sung, Nak Yun ; Yang, Mi So ; Song, Du Sub ; Kim, Jae Kyung ; Park, Jong Heum ; Song, Beom Seok ; Park, Sang Hyun ; Lee, Ju Woon ; Park, Hyun Jin ; Kim, Jae Hun ; Byun, Eui Baek ; Byun, Eui Hong. / Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages. In: Biochemical and Biophysical Research Communications. 2013 ; Vol. 438, No. 1. pp. 122-128.
@article{7192507f2ef94f04b530233050483be2,
title = "Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages",
abstract = "Polyphenolic compounds have been found to possess a wide range of physiological activities that may contribute to their beneficial effects against inflammation-related diseases; however, the molecular mechanisms underlying this anti-inflammatory activity are not completely characterized, and many features remain to be elucidated. In this study, we investigated the molecular basis for the down-regulation of toll-like receptor 4 (TLR4) signal transduction by procyanidin dimer B2 (Pro B2) in macrophages. Pro B2 markedly elevated the expression of the interleukin (IL)-1 receptor-associated kinase (IRAK)-M protein, a negative regulator of TLR signaling. Lipopolysaccharide (LPS)-induced expression of cell surface molecules (CD80, CD86, and MHC class I/II) and production of pro-inflammatory cytokines (tumor necrosis factor-α, IL-1β, IL-6, and IL-12p70) were inhibited by Pro B2, and this action was prevented by IRAK-M silencing. In addition, Pro B2-treated macrophages inhibited LPS-induced activation of mitogen-activated protein kinases such as extracellular signal-regulated kinase 1/2, p38, and c-Jun N-terminal kinase and the translocation of nuclear factor κB and p65 through IRAK-M. We also found that Pro B2-treated macrophages inactivated na{\"i}ve T cells by inhibiting LPS-induced interferon-γ and IL-2 secretion through IRAK-M. These novel findings provide new insights into the understanding of negative regulatory mechanisms of the TLR4 signaling pathway and the immune-pharmacological role of Pro B2 in the immune response against the development and progression of many chronic diseases.",
keywords = "Cytokine, Mitogen-activated protein kinases, Nuclear factor κB, Procyanidin B2, Toll-like receptor",
author = "Sung, {Nak Yun} and Yang, {Mi So} and Song, {Du Sub} and Kim, {Jae Kyung} and Park, {Jong Heum} and Song, {Beom Seok} and Park, {Sang Hyun} and Lee, {Ju Woon} and Park, {Hyun Jin} and Kim, {Jae Hun} and Byun, {Eui Baek} and Byun, {Eui Hong}",
year = "2013",
month = "8",
day = "16",
doi = "10.1016/j.bbrc.2013.07.038",
language = "English",
volume = "438",
pages = "122--128",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages

AU - Sung, Nak Yun

AU - Yang, Mi So

AU - Song, Du Sub

AU - Kim, Jae Kyung

AU - Park, Jong Heum

AU - Song, Beom Seok

AU - Park, Sang Hyun

AU - Lee, Ju Woon

AU - Park, Hyun Jin

AU - Kim, Jae Hun

AU - Byun, Eui Baek

AU - Byun, Eui Hong

PY - 2013/8/16

Y1 - 2013/8/16

N2 - Polyphenolic compounds have been found to possess a wide range of physiological activities that may contribute to their beneficial effects against inflammation-related diseases; however, the molecular mechanisms underlying this anti-inflammatory activity are not completely characterized, and many features remain to be elucidated. In this study, we investigated the molecular basis for the down-regulation of toll-like receptor 4 (TLR4) signal transduction by procyanidin dimer B2 (Pro B2) in macrophages. Pro B2 markedly elevated the expression of the interleukin (IL)-1 receptor-associated kinase (IRAK)-M protein, a negative regulator of TLR signaling. Lipopolysaccharide (LPS)-induced expression of cell surface molecules (CD80, CD86, and MHC class I/II) and production of pro-inflammatory cytokines (tumor necrosis factor-α, IL-1β, IL-6, and IL-12p70) were inhibited by Pro B2, and this action was prevented by IRAK-M silencing. In addition, Pro B2-treated macrophages inhibited LPS-induced activation of mitogen-activated protein kinases such as extracellular signal-regulated kinase 1/2, p38, and c-Jun N-terminal kinase and the translocation of nuclear factor κB and p65 through IRAK-M. We also found that Pro B2-treated macrophages inactivated naïve T cells by inhibiting LPS-induced interferon-γ and IL-2 secretion through IRAK-M. These novel findings provide new insights into the understanding of negative regulatory mechanisms of the TLR4 signaling pathway and the immune-pharmacological role of Pro B2 in the immune response against the development and progression of many chronic diseases.

AB - Polyphenolic compounds have been found to possess a wide range of physiological activities that may contribute to their beneficial effects against inflammation-related diseases; however, the molecular mechanisms underlying this anti-inflammatory activity are not completely characterized, and many features remain to be elucidated. In this study, we investigated the molecular basis for the down-regulation of toll-like receptor 4 (TLR4) signal transduction by procyanidin dimer B2 (Pro B2) in macrophages. Pro B2 markedly elevated the expression of the interleukin (IL)-1 receptor-associated kinase (IRAK)-M protein, a negative regulator of TLR signaling. Lipopolysaccharide (LPS)-induced expression of cell surface molecules (CD80, CD86, and MHC class I/II) and production of pro-inflammatory cytokines (tumor necrosis factor-α, IL-1β, IL-6, and IL-12p70) were inhibited by Pro B2, and this action was prevented by IRAK-M silencing. In addition, Pro B2-treated macrophages inhibited LPS-induced activation of mitogen-activated protein kinases such as extracellular signal-regulated kinase 1/2, p38, and c-Jun N-terminal kinase and the translocation of nuclear factor κB and p65 through IRAK-M. We also found that Pro B2-treated macrophages inactivated naïve T cells by inhibiting LPS-induced interferon-γ and IL-2 secretion through IRAK-M. These novel findings provide new insights into the understanding of negative regulatory mechanisms of the TLR4 signaling pathway and the immune-pharmacological role of Pro B2 in the immune response against the development and progression of many chronic diseases.

KW - Cytokine

KW - Mitogen-activated protein kinases

KW - Nuclear factor κB

KW - Procyanidin B2

KW - Toll-like receptor

UR - http://www.scopus.com/inward/record.url?scp=84881551722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881551722&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2013.07.038

DO - 10.1016/j.bbrc.2013.07.038

M3 - Article

VL - 438

SP - 122

EP - 128

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 1

ER -